We are Heading to ASHG 2023!

         October 20, 2023

Explore the Newest Developments in Variant Classification and Interpretation Tools at Booth 506 at ASHG 2023

Join Golden Helix at the American Society of Human Genetics (ASHG) 2023 conference and delve into the latest advancements in genetic research. This esteemed event brings together distinguished researchers, clinicians, and industry frontrunners to exchange knowledge on the most recent insights in human genetics.

At Golden Helix’s booth, you’ll have the opportunity to delve deeper into our cutting-edge genetic analysis tools. Our inclusive range of software solutions features VarSeq, VS-CNV, VSClinical, VSPipeline, and VSWarehouse, providing potent and intuitive solutions for genomic analysis and interpretation, aligned with the ACMG and AMP Guidelines.

Drop by our booth to witness a live demonstration of our software, learn about the latest enhancements, and discuss how our tools can elevate your genetic research endeavors. Plus, if you attend our booth for a demo, you’ll get one of our exclusive t-shirts as a token of appreciation.

Seize this chance to explore the forefront of genetic analysis tools and engage with our proficient team at ASHG 2023. We’re eager to connect with you!

Locate us at Booth #506
Make a point to swing by Booth #506 for dynamic product demonstrations and to converse with our team about your specific requirements. Additionally, grab the opportunity to secure our newly designed t-shirts, made exclusively for ASHG demo participants. We hope to see you there!

ASHG Booth #506 2023 Demo Schedule

Ensure you don’t miss out on witnessing our advanced software tools in action! Throughout the conference exhibition, our team will be hosting concise software demonstrations at our booth. Swing by and discover how our robust yet easy-to-use tools can elevate your genomic analysis and interpretation.

  • Thursday, November 2:
    • 10:10 – Whole Genome NGS Analysis with VarSeq and VSClinical
    • 10:30 – NGS Copy Number Variant Calling and Interpretation – A Complete Clinical Workflow
    • 12:25 – Somatic NGS Workflow with VarSeq – Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
    • 12:55 – VarSeq: The Tertiary Analysis Solution for NGS
    • 3:10 – Carrier Status Analysis in VarSeq
    • 4:00 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
  • Friday, November 3:
    • 10:10 – Whole Genome NGS Analysis with VarSeq and VSClinical
    • 10:30 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
    • 12:20 – 12:50 CoLab Session (CoLab Theater 2): From Panels to Whole Genomes with VarSeq: The complete tertiary platform for short and long-read NGS data
    • 1:15 – VarSeq: The Tertiary Analysis Solution for NGS
    • 3:10 – Carrier Status Analysis in VarSeq
    • 4:00 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
  • Saturday, November 4:
    • 10:10 – Carrier Status Analysis in VarSeq
    • 12:10 – Somatic NGS Workflow with VarSeq – Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
    • 12:40 – Whole Genome NGS Analysis with VarSeq and VSClinical
    • 2:15 – NGS Enterprise Capabilities – Automation, Warehousing, Continuous Improvement
    • 3:30 – NGS Copy Number Variant Calling and Interpretation – A Complete Clinical Workflow
    • 4:00 – VarSeq: The Tertiary Analysis Solution for NGS

CoLab Session

Panels to Whole Genomes with VarSeq: The Complete Tertiary Platform for Short and Long-Read NGS Data
Friday, November 3rd, 12:20, CoLab Theater 2

Presented by: Andreas Scherer, PhD, Golden Helix CEO and President & Dr. Jennifer Dankoff, FAS

Join us as we unveil the flexibility and capabilities of the Golden Helix software suite. From managing the tiniest panels to the most recent long-read genomes—even at a population scale—VarSeq can handle a broad spectrum of variant types (SNV, Indel, CNV, Fusions). Furthermore, it offers automated classification and reporting features in accordance with the ACMG and AMP guidelines.

Leave a Reply

Your email address will not be published. Required fields are marked *